NASDAQ:SMLR Semler Scientific (SMLR) Stock Price, News & Analysis $41.57 -1.82 (-4.19%) As of 02:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Semler Scientific Stock (NASDAQ:SMLR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Semler Scientific alerts:Sign Up Key Stats Today's Range$40.44▼$43.1750-Day Range$29.83▼$44.9352-Week Range$21.77▼$81.56Volume589,045 shsAverage Volume495,810 shsMarket Capitalization$463.92 millionP/E Ratio8.47Dividend YieldN/APrice Target$71.00Consensus RatingBuy Company OverviewSemler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.Read More… Semler Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreSMLR MarketRank™: Semler Scientific scored higher than 50% of companies evaluated by MarketBeat, and ranked 545th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingSemler Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageSemler Scientific has received no research coverage in the past 90 days.Read more about Semler Scientific's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Semler Scientific is 8.49, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.87.Price to Earnings Ratio vs. SectorThe P/E ratio of Semler Scientific is 8.49, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.91.Price to Book Value per Share RatioSemler Scientific has a P/B Ratio of 3.99. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Semler Scientific's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted21.88% of the float of Semler Scientific has been sold short.Short Interest Ratio / Days to CoverSemler Scientific has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Semler Scientific has recently increased by 1.80%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSemler Scientific does not currently pay a dividend.Dividend GrowthSemler Scientific does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted21.88% of the float of Semler Scientific has been sold short.Short Interest Ratio / Days to CoverSemler Scientific has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Semler Scientific has recently increased by 1.80%, indicating that investor sentiment is decreasing. News and Social Media2.6 / 5News Sentiment0.71 News SentimentSemler Scientific has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Semler Scientific this week, compared to 3 articles on an average week.Search Interest9 people have searched for SMLR on MarketBeat in the last 30 days. This is an increase of 800% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Semler Scientific insiders have not sold or bought any company stock.Percentage Held by Insiders30.20% of the stock of Semler Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions49.37% of the stock of Semler Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Semler Scientific's insider trading history. Receive SMLR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Semler Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address SMLR Stock News HeadlinesSemler Scientific Inc. (SMLR) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMay 26 at 10:03 AM | tmcnet.comSemler Scientific Inc. (SMLR) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMay 26 at 9:00 AM | businesswire.comF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry.May 28, 2025 | The Tomorrow Investor (Ad)Securities Fraud Investigation Into Semler Scientific Inc. (SMLR) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law FirmMay 23, 2025 | businesswire.comSecurities Fraud Investigation Into Semler Scientific Inc. (SMLR) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. CruzMay 23, 2025 | businesswire.comSemler Scientific Sees Unusually High Options Volume (NASDAQ:SMLR)May 23, 2025 | americanbankingnews.comSEMLER ALERT: Bragar Eagel & Squire, P.C. is Investigating Semler Scientific Inc. on Behalf of Semler Stockholders and Encourages Investors to Contact the FirmMay 22, 2025 | globenewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating Semler Scientific Inc.May 19, 2025 | prnewswire.comSee More Headlines SMLR Stock Analysis - Frequently Asked Questions How have SMLR shares performed this year? Semler Scientific's stock was trading at $54.00 at the start of the year. Since then, SMLR stock has decreased by 22.7% and is now trading at $41.7450. View the best growth stocks for 2025 here. How were Semler Scientific's earnings last quarter? Semler Scientific, Inc. (NASDAQ:SMLR) released its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The company had revenue of $8.84 million for the quarter. Semler Scientific had a trailing twelve-month return on equity of 50.77% and a net margin of 72.65%. Read the conference call transcript. Who are Semler Scientific's major shareholders? Semler Scientific's top institutional investors include Interchange Capital Partners LLC (13.39%), Driehaus Capital Management LLC (1.95%), Charles Schwab Investment Management Inc. (1.65%) and Shariaportfolio Inc. (1.09%). View institutional ownership trends. How do I buy shares of Semler Scientific? Shares of SMLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Semler Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Semler Scientific investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), Netflix (NFLX), Arista Networks (ANET) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings5/13/2025Today5/28/2025Next Earnings (Estimated)8/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:SMLR CIK1554859 Webwww.semlerscientific.com Phone877-774-4211FaxN/AEmployees120Year FoundedN/APrice Target and Rating Average Stock Price Target$71.00 High Stock Price Target$71.00 Low Stock Price Target$71.00 Potential Upside/Downside+63.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($2.61) Trailing P/E Ratio8.84 Forward P/E RatioN/A P/E GrowthN/ANet Income$20.58 million Net Margins72.65% Pretax Margin30.75% Return on Equity50.77% Return on Assets47.04% Debt Debt-to-Equity RatioN/A Current Ratio3.14 Quick Ratio3.09 Sales & Book Value Annual Sales$49.23 million Price / Sales9.83 Cash Flow$2.56 per share Price / Cash Flow16.95 Book Value$10.45 per share Price / Book4.15Miscellaneous Outstanding Shares11,152,000Free Float6,468,000Market Cap$483.89 million OptionableNot Optionable Beta1.33 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:SMLR) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semler Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.